ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $291,000 | +2.8% | 199,052 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $283,000 | -18.7% | 199,052 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $348,000 | +2.4% | 199,052 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $340,000 | -13.3% | 199,052 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $392,000 | +3.7% | 199,052 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $378,000 | -0.5% | 199,052 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $380,000 | -58.9% | 199,052 | 0.0% | 0.00% | -66.7% |
Q2 2015 | $924,000 | +6.2% | 199,052 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $870,000 | +25.9% | 199,052 | 0.0% | 0.00% | +50.0% |
Q4 2014 | $691,000 | -17.1% | 199,052 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $834,000 | -28.5% | 199,052 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $1,166,000 | -7.0% | 199,052 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $1,254,000 | +7.7% | 199,052 | 0.0% | 0.00% | +33.3% |
Q4 2013 | $1,164,000 | -5.8% | 199,052 | -15.1% | 0.00% | -25.0% |
Q3 2013 | $1,236,000 | -19.4% | 234,507 | +17.8% | 0.00% | -20.0% |
Q2 2013 | $1,533,000 | – | 199,052 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |